FR2206948A1 - - Google Patents

Info

Publication number
FR2206948A1
FR2206948A1 FR7341144A FR7341144A FR2206948A1 FR 2206948 A1 FR2206948 A1 FR 2206948A1 FR 7341144 A FR7341144 A FR 7341144A FR 7341144 A FR7341144 A FR 7341144A FR 2206948 A1 FR2206948 A1 FR 2206948A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7341144A
Other versions
FR2206948B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of FR2206948A1 publication Critical patent/FR2206948A1/fr
Application granted granted Critical
Publication of FR2206948B1 publication Critical patent/FR2206948B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7341144A 1972-11-17 1973-11-19 Expired FR2206948B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2256445A DE2256445C3 (de) 1972-11-17 1972-11-17 Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Publications (2)

Publication Number Publication Date
FR2206948A1 true FR2206948A1 (fr) 1974-06-14
FR2206948B1 FR2206948B1 (fr) 1978-01-13

Family

ID=5862026

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341144A Expired FR2206948B1 (fr) 1972-11-17 1973-11-19

Country Status (15)

Country Link
US (1) US3931141A (fr)
JP (1) JPS5724778B2 (fr)
AT (1) AT329203B (fr)
BE (1) BE807501A (fr)
CA (1) CA1012965A (fr)
CH (1) CH587802A5 (fr)
DE (1) DE2256445C3 (fr)
DK (1) DK147733C (fr)
ES (1) ES420458A1 (fr)
FR (1) FR2206948B1 (fr)
GB (1) GB1429700A (fr)
IL (1) IL43632A (fr)
NL (1) NL181331C (fr)
SE (1) SE394426B (fr)
ZA (1) ZA738785B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012401A1 (fr) * 1978-12-11 1980-06-25 Merck & Co. Inc. Dérivés de carboxyalcoyl-dipeptide, procédé pour leur préparation et composition pharmaceutique les contenant

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628006C2 (de) * 1976-06-23 1986-11-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
DE3061586D1 (en) * 1979-04-30 1983-02-17 Max Planck Gesellschaft Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
US4530836A (en) * 1983-05-31 1985-07-23 Amano Pharmaceutical Co., Ltd. Peptide
JPS6194392A (ja) * 1984-10-15 1986-05-13 富士通テン株式会社 基板接続方法
IT1204430B (it) * 1986-01-10 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
EP0380230B1 (fr) * 1989-01-24 1994-11-17 Aphton Corporation Compositions immunogéniques contre des peptides du type gastrine
US6861510B1 (en) 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
ES2227833T3 (es) * 1997-05-12 2005-04-01 Aphton Corporation Composiciones inmunogenicas para el receptor cck-b/gastrina y metodos para el tratamiento de tumores.
PT1077721E (pt) * 1998-05-15 2007-06-21 Receptor Biologix Inc Prevenção e tratamento da hipergastrinemia.
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
WO2002076499A2 (fr) 2001-03-23 2002-10-03 Aphton Corporation Traitement combine du cancer du pancreas
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
AU2004225437B2 (en) 2003-03-28 2010-05-13 Cancer Advances, Inc. Gastrin hormone immunoassays
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
AU2005228897B2 (en) * 2004-03-29 2009-12-10 Cancer Advances, Inc. Monoclonal antibodies to gastrin hormone
EP2567974A3 (fr) * 2004-09-22 2013-05-22 Cancer Advances, Inc., Anticorps monoclonaux contre la progastrine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665591A (fr) * 1964-06-25 1965-12-17

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1224576A (en) * 1968-08-24 1971-03-10 Tanabe Seiyaku Co Novel tetrapeptide amides and the preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665591A (fr) * 1964-06-25 1965-12-17

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012401A1 (fr) * 1978-12-11 1980-06-25 Merck & Co. Inc. Dérivés de carboxyalcoyl-dipeptide, procédé pour leur préparation et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
SE394426B (sv) 1977-06-27
IL43632A0 (en) 1974-03-14
DE2256445C3 (de) 1981-11-05
ES420458A1 (es) 1976-04-01
CA1012965A (en) 1977-06-28
DE2256445A1 (de) 1974-05-22
NL7315444A (fr) 1974-05-21
BE807501A (fr) 1974-05-20
AT329203B (de) 1976-04-26
FR2206948B1 (fr) 1978-01-13
NL181331B (nl) 1987-03-02
US3931141A (en) 1976-01-06
DE2256445B2 (de) 1980-11-20
IL43632A (en) 1976-09-30
GB1429700A (en) 1976-03-24
DK147733B (da) 1984-11-26
CH587802A5 (fr) 1977-05-13
JPS504067A (fr) 1975-01-16
ZA738785B (en) 1974-10-30
NL181331C (nl) 1987-08-03
ATA964673A (de) 1975-07-15
AU6249773A (en) 1975-05-15
JPS5724778B2 (fr) 1982-05-26
DK147733C (da) 1985-06-17

Similar Documents

Publication Publication Date Title
FR2206948B1 (fr)
CS153888B1 (fr)
CS165292B1 (fr)
JPS4923561A (fr)
JPS5039962Y2 (fr)
JPS541455B2 (fr)
JPS48110308U (fr)
JPS4891992A (fr)
JPS4998887U (fr)
JPS4936679U (fr)
CS150894B1 (fr)
CS153923B1 (fr)
CS154184B1 (fr)
CS156905B1 (fr)
CS158104B1 (fr)
CS163911B1 (fr)
CS163972B1 (fr)
JPS497289A (fr)
JPS4981232U (fr)
CH578631A5 (fr)
CH576093A5 (fr)
CH574545A5 (fr)
CH575305A5 (fr)
CH574197A5 (fr)
CH575777A5 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse